Thaiger Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 5.13 M
as on 14-12-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 132.83%
(FY 2022)
- Profit 232.10%
(FY 2022)
- Ebitda 133.10%
(FY 2022)
- Net Worth 0.17%
(FY 2022)
- Total Assets 34.39%
(FY 2022)
About Thaiger Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.13 M, as per Ministry of Corporate Affairs (MCA) records.
Irfan Dhorajiwala and Aftab Attarwala serve as directors at the Company.
- CIN/LLPIN
U24100MH2014PTC253312
- Company No.
253312
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2014
- Date of AGM
24 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Thaiger Pharma Private Limited offer?
Thaiger Pharma Private Limited offers a wide range of products and services, including Injectable Products.
Who are the key members and board of directors at Thaiger Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Irfan Dhorajiwala  | Director | 17-Feb-2014 | Current |
| Aftab Attarwala | Director | 27-Mar-2023 | Current |
Financial Performance of Thaiger Pharma.
Thaiger Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 132.83% increase. The company also saw a substantial improvement in profitability, with a 232.1% increase in profit. The company's net worth moved up by a moderate rise of 0.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Thaiger Pharma?
In 2021, Thaiger Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Thaiger Pharma?
Unlock and access historical data on people associated with Thaiger Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Thaiger Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thaiger Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
